Hyperfine to Announce First Quarter 2022 Financial Results on May 11, 2022
Hyperfine, Inc. (Nasdaq: HYPR) has announced it will release its first quarter 2022 financial results on May 11, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Hyperfine, Inc. (Nasdaq: HYPR) has announced it will release its first quarter 2022 financial results on May 11, 2022. The company, known for creating the world's first FDA-cleared portable MRI system, Swoop®, will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss these results. Interested investors can listen by calling specified numbers or via a live webcast on Hyperfine's investor page. The Swoop system aims to enhance patient access to medical imaging, enabling rapid diagnoses in various clinical settings.
Positive
- The upcoming Q1 2022 financial results announcement on May 11, 2022, could provide insights into the company's growth and performance.
- Swoop® is positioned as a cost-effective alternative to traditional MRIs, which may enhance market adoption.
Negative
- None.
Details
News Market Reaction – HYPR
The recorded move for HYPR in the trading session of this news was +5.19%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GUILFORD, Conn., April 20, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the first quarter 2022 on Wednesday, May 11, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by dialing (888) 708-1168 for domestic callers or (630) 652-5889 for international callers, using conference ID 4080148. A live audio webcast and an archive of the presentation will be available through the Investors page of Hyperfine’s corporate website at https://investors.hyperfine.io/.
About Hyperfine
Hyperfine, Inc. is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System™ produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.
Investor Contact
Marissa Bych
Gilmartin Group LLC
investors@hyperfine.io
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.